Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Valuation of the anti-virus platform

<< Previous

Bullboard Posts

Next >>

Comment by LaserStock29on Apr 18, 2022 5:41pm

104 Views

Post# 34611482

RE:RE:RE:Valuation of the anti-virus platform

Again, the question is.... if there is a grant that has been already applied to that can be approved before the AGM?

the other question is the cash on hand.. i would like confirmation from management that the initial 17m allocated and broken down for 100+ patients.. is fully covered and no additional pp will be required.

socksnblonds642 wrote: Need human trials to have much of an affect on SP. Wonder how much current safety results play into things though. Would at least help get participants for a trial IF it were to happen. Big IF.

<< Previous

Bullboard Posts

Next >>

New CEO leads Sonoro Energy's vision to expand in MENA